Latest Insider Transactions at Bausch Health Companies Inc. (BHC)
This section provides a real-time view of insider transactions for Bausch Health Companies Inc. (BHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bausch Health Companies Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bausch Health Companies Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,298
+10.31%
|
-
|
|
Mar 03
2021
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
23,892
+19.26%
|
-
|
|
Mar 03
2021
|
Paul Herendeen EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
63,439
+15.48%
|
-
|
|
Mar 03
2021
|
Joseph C Papa Director |
BUY
Grant, award, or other acquisition
|
Direct |
74,150
+8.06%
|
-
|
|
Mar 03
2021
|
Robert Spurr President, U.S. Businesses |
BUY
Grant, award, or other acquisition
|
Direct |
23,892
+28.71%
|
-
|
|
Mar 01
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
5,367
-4.32%
|
$166,377
$31.42 P/Share
|
|
Mar 01
2021
|
Thomas Appio Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,436
-2.96%
|
$168,516
$31.42 P/Share
|
|
Mar 01
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,739
-2.15%
|
$53,909
$31.42 P/Share
|
|
Mar 01
2021
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
3,313
-4.16%
|
$102,703
$31.42 P/Share
|
|
Mar 01
2021
|
Paul Herendeen EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,755
-5.28%
|
$488,405
$31.42 P/Share
|
|
Mar 01
2021
|
Joseph C Papa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
28,192
-3.52%
|
$873,952
$31.42 P/Share
|
|
Mar 01
2021
|
Robert Spurr President, U.S. Businesses |
SELL
Payment of exercise price or tax liability
|
Direct |
3,252
-8.4%
|
$100,812
$31.42 P/Share
|
|
Dec 31
2020
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,622
+0.54%
|
$32,440
$20.8 P/Share
|
|
Dec 31
2020
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,442
+1.93%
|
$28,840
$20.8 P/Share
|
|
Dec 31
2020
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,802
+1.56%
|
$36,040
$20.8 P/Share
|
|
Dec 31
2020
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
330
+0.32%
|
$6,600
$20.8 P/Share
|
|
Dec 15
2020
|
Thomas Appio Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,224
-1.73%
|
$64,480
$20.61 P/Share
|
|
Dec 04
2020
|
William D. Humphries President, Ortho-Dermatologics |
SELL
Open market or private sale
|
Direct |
114,055
-32.67%
|
$2,167,045
$19.87 P/Share
|
|
Dec 04
2020
|
William D. Humphries President, Ortho-Dermatologics |
BUY
Exercise of conversion of derivative security
|
Direct |
114,055
+24.63%
|
$1,596,770
$14.38 P/Share
|
|
Nov 27
2020
|
William D. Humphries President, Ortho-Dermatologics |
SELL
Open market or private sale
|
Direct |
13,663
-5.49%
|
$259,597
$19.63 P/Share
|
|
Nov 27
2020
|
William D. Humphries President, Ortho-Dermatologics |
BUY
Exercise of conversion of derivative security
|
Direct |
13,663
+5.21%
|
$191,282
$14.38 P/Share
|
|
Nov 24
2020
|
William D. Humphries President, Ortho-Dermatologics |
SELL
Open market or private sale
|
Direct |
21,658
-8.44%
|
$411,502
$19.63 P/Share
|
|
Nov 24
2020
|
William D. Humphries President, Ortho-Dermatologics |
BUY
Exercise of conversion of derivative security
|
Direct |
21,658
+7.74%
|
$303,212
$14.38 P/Share
|
|
Nov 23
2020
|
William D. Humphries President, Ortho-Dermatologics |
SELL
Open market or private sale
|
Direct |
1,483
-0.63%
|
$28,177
$19.63 P/Share
|
|
Nov 23
2020
|
William D. Humphries President, Ortho-Dermatologics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,483
+0.62%
|
$20,762
$14.38 P/Share
|
|
Oct 02
2020
|
Robert Spurr President, U.S. Businesses |
SELL
Payment of exercise price or tax liability
|
Direct |
276
-0.71%
|
$4,140
$15.89 P/Share
|
|
Sep 30
2020
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,171
+0.73%
|
$32,565
$15.54 P/Share
|
|
Sep 30
2020
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+2.61%
|
$28,950
$15.54 P/Share
|
|
Sep 30
2020
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,413
+2.11%
|
$36,195
$15.54 P/Share
|
|
Sep 30
2020
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
442
+0.44%
|
$6,630
$15.54 P/Share
|
|
Jun 05
2020
|
Value Act Holdings, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
948,353
+5.02%
|
$18,018,707
$19.24 P/Share
|
|
Jun 05
2020
|
Value Act Holdings, L.P. Director |
SELL
Open market or private sale
|
Indirect |
948,353
-100.0%
|
$18,018,707
$19.24 P/Share
|
|
May 01
2020
|
David Robert Hale Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,037
+34.4%
|
-
|
|
Apr 29
2020
|
David Robert Hale Director |
SELL
Payment of exercise price or tax liability
|
Direct |
624
-5.87%
|
$11,232
$18.11 P/Share
|
|
Jun 13
2019
|
Value Act Holdings, L.P. Director |
SELL
Other acquisition or disposition
|
Indirect |
111,440
-10.52%
|
-
|
|
May 03
2019
|
David Robert Hale Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,633
+34.13%
|
$244,559
$23.51 P/Share
|
|
May 01
2019
|
David Robert Hale Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,996
-28.79%
|
$91,908
$23.63 P/Share
|
|
May 03
2018
|
David Robert Hale Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,285
+28.47%
|
-
|
|
May 01
2018
|
David Robert Hale Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,794
-14.93%
|
$68,292
$18.07 P/Share
|